(Q39348693)

11 September 2017

Long-term use of bisphosphonates in osteoporosis (English)

1 reference

11 September 2017

0 references

Basmah K Alwahhabi

1

1 reference

PMCID

5541183

11 September 2017

Basil A Alsuwaine

series ordinal

2

1 reference

11 September 2017

1 June 2017

1 reference

11 September 2017

Saudi Medical Journal

1 reference

11 September 2017

38

1 reference

11 September 2017

6

1 reference

11 September 2017

604-608

1 reference

Atypical femoral fracture after receiving antiresorptive drugs in breast cancer patients with bone metastasis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Atypical femoral fracture in a beta-thalassemia major patient with previous bisphosphonate use: case report and a review of the literature

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Effect of Teriparatide on Healing of Atypical Femoral Fractures: A Systemic Review

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Weekly Teriparatide for Delayed Unions of Atypical Subtrochanteric Femur Fractures

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Glucocorticoid-induced osteoporosis: treatment update and review.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Potential and pitfalls of using large administrative claims data to study the safety of osteoporosis therapies.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Severely suppressed bone turnover: a potential complication of alendronate therapy

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Effects of high-dose etidronate treatment on microdamage accumulation and biomechanical properties in beagle bone before occurrence of spontaneous fractures

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5541183

Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28578439

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28578439

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Should bisphosphonates be continued indefinitely? An unusual fracture in a healthy woman on long-term alendronate

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28578439

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.15537/SMJ.2017.6.19793

1 reference

11 September 2017

1 reference

11 September 2017

1 reference

PMCID

5541183